Skip to content
CELLSWAY
Menu
  • About Us
    • Company
    • Team
      • Management Team
      • All Team
    • Investors
    • Clinical Collaborations
    • Advisory Board
  • Technology
    • Liquid Biopsy & CTCs
    • Our Technology
    • Publications
  • Products
    • CTC Enrichment Device
    • CTC Enrichment Chip
    • CTC Test Panels
      • CTC Identification Panel
      • ER/PR/Her2 CTC Panel
      • The PD-L1 CTC Panel
  • News & Events
  • Contact

Author: cellsway_web_admin

News

Halfway through the Clinical Study Optimizing Cellsway’s CTC Workflow for Enhanced Cancer Care

The 300-patient study is designed for optimizing Cellsway’s CTC enrichment, identification and characterization workflow with clinical samples. The patients for the study are being selected from newly diagnosed Stage III/IV …

Press Releases

Cellsway and Omega Genetik Sign Strategic Cooperation Agreement

ANKARA, ÇANKAYA, TURKEY, May 17, 2023/EINPresswire/ — Cellsway, a deep-tech liquid biopsy company, and Omega Genetik, a leading genetics lab have entered into a partnership and commercialization agreement to provide …

News

Turkish news agency Anadolu Ajansı (AA) interviewed with Cellsway team about its CTC liquid biopsy platform

You can reach the whole interview in English and in Turkish.

News & Events

  • News (8)
  • Press Releases (1)

Latest News

  • Halfway through the Clinical Study Optimizing Cellsway’s CTC Workflow for Enhanced Cancer Care November 29, 2023
  • Cellsway and Omega Genetik Sign Strategic Cooperation Agreement July 21, 2023
  • Turkish news agency Anadolu Ajansı (AA) interviewed with Cellsway team about its CTC liquid biopsy platform October 26, 2022

Comments

    Join our Newsletter
    Keep Updated
    Copyright © 2025 CELLSWAY

    We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies